CFTR and cystic fibrosis: Further modifications led to another AmB derivative, C2’epiAmB-AA, that also minimized cholesterol binding and thus toxicity to cultured CF airway epithelia and was an effective surrogate for CFTR in primary cultured airway epithelia from people with CF.